| Product Code: ETC13203750 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Celiac Drugs Market was valued at USD 0.92 Billion in 2024 and is expected to reach USD 1.3 Billion by 2031, growing at a compound annual growth rate of 4.70% during the forecast period (2025-2031).
The Global Celiac Drugs Market is witnessing growth due to the increasing prevalence of celiac disease worldwide. Celiac disease is an autoimmune disorder triggered by gluten consumption, leading to damage in the small intestine. The market is driven by the rising awareness of celiac disease, improved diagnostic techniques, and the development of novel drug therapies. Key players in the market are focusing on research and development activities to introduce innovative treatment options. Additionally, collaborations and partnerships between pharmaceutical companies and research organizations are contributing to market growth. The market is expected to continue expanding as healthcare infrastructure improves in developing regions and as more patients are diagnosed with celiac disease. Overall, the Global Celiac Drugs Market is poised for significant growth in the coming years.
The Global Celiac Drugs Market is witnessing a surge in growth due to the increasing prevalence of celiac disease and gluten intolerance worldwide. The market is driven by the rising awareness about the condition, improved diagnosis rates, and the development of innovative drugs catering to the specific needs of celiac patients. Additionally, advancements in drug delivery technologies and the introduction of novel therapies are creating opportunities for market expansion. The market is also benefiting from collaborations between pharmaceutical companies and research institutions to develop more effective and targeted treatment options. With a growing number of patients seeking pharmaceutical interventions to manage their condition, the Global Celiac Drugs Market is poised for further growth and innovation in the coming years.
The Global Celiac Drugs Market faces several challenges, including limited awareness about celiac disease and available treatment options among healthcare professionals and patients, leading to underdiagnosis and undertreatment. Additionally, the high cost of celiac drugs and lack of insurance coverage in some regions hinder patient access to necessary medications. There is also a lack of effective pharmacological treatments for celiac disease, with the current options focusing on symptom management rather than addressing the underlying cause. Regulatory hurdles and the lengthy process of drug development for celiac disease further contribute to the challenges faced by pharmaceutical companies in bringing new therapies to the market. Overall, addressing these challenges is crucial to improving the quality of life for individuals with celiac disease and advancing the Global Celiac Drugs Market.
The Global Celiac Drugs Market is primarily driven by the increasing prevalence of celiac disease worldwide, leading to a growing demand for effective treatment options. Additionally, rising awareness about the disease among healthcare professionals and patients, advancements in diagnostic technologies for accurate diagnosis, and the development of novel drug therapies are also key drivers fueling market growth. Furthermore, the adoption of a gluten-free diet as a primary treatment for celiac disease and the availability of government initiatives supporting celiac disease management are contributing factors shaping the market landscape. Overall, the expanding patient pool, coupled with the focus on research and development activities by pharmaceutical companies to introduce innovative treatment solutions, is expected to propel the Global Celiac Drugs Market in the coming years.
Government policies related to the Global Celiac Drugs Market primarily focus on regulating the safety and efficacy of celiac disease treatments, promoting research and development in the field, and ensuring access to affordable treatment options for patients. Regulatory agencies such as the FDA in the United States and the EMA in Europe play a crucial role in approving celiac drugs based on clinical trials and evidence of effectiveness. These agencies also monitor the labeling and marketing of celiac drugs to ensure accurate information for patients. Additionally, governments may provide funding or incentives for companies to invest in celiac drug research and development, aiming to expand treatment options for those with celiac disease. Overall, government policies aim to support the growth of the celiac drugs market while ensuring patient safety and access to effective treatments.
The Global Celiac Drugs Market is expected to witness steady growth in the coming years, driven by increasing awareness about celiac disease, growing diagnosis rates, and advancements in drug development. The market is likely to be fueled by the rising prevalence of celiac disease worldwide, particularly in developed countries where gluten-free diets are becoming more popular. Additionally, ongoing research and development efforts to introduce novel therapies and treatments for celiac disease are anticipated to further boost market growth. However, challenges such as limited treatment options and varying regulatory landscapes across different regions may pose some constraints. Overall, the Global Celiac Drugs Market is poised for expansion as the demand for effective treatments for celiac disease continues to rise.
In the global celiac drugs market, North America holds the largest market share due to the high prevalence of celiac disease in the region and the presence of advanced healthcare infrastructure. Europe follows closely behind, driven by increased awareness about celiac disease and the availability of innovative treatment options. The Asia Pacific region is expected to witness significant growth in the coming years, fueled by the rising incidence of celiac disease and improving healthcare facilities. In contrast, the Middle East and Africa, and Latin America regions are projected to experience slower growth due to lower awareness levels and limited access to celiac disease diagnosis and treatment. However, as healthcare infrastructure continues to develop in these regions, there is potential for increased market penetration of celiac drugs in the future.
Global Celiac Drugs Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Celiac Drugs Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Celiac Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Global Celiac Drugs Market - Industry Life Cycle |
3.4 Global Celiac Drugs Market - Porter's Five Forces |
3.5 Global Celiac Drugs Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Celiac Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Celiac Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Celiac Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Global Celiac Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Global Celiac Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Celiac Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Celiac Drugs Market Trends |
6 Global Celiac Drugs Market, 2021 - 2031 |
6.1 Global Celiac Drugs Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Celiac Drugs Market, Revenues & Volume, By Biological Drugs, 2021 - 2031 |
6.1.3 Global Celiac Drugs Market, Revenues & Volume, By Immunosuppresants, 2021 - 2031 |
6.1.4 Global Celiac Drugs Market, Revenues & Volume, By Corticosteroids, 2021 - 2031 |
6.1.5 Global Celiac Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Celiac Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Celiac Drugs Market, Revenues & Volume, By Classical Celiac Disease, 2021 - 2031 |
6.2.3 Global Celiac Drugs Market, Revenues & Volume, By Non- Classical Celiac Disease, 2021 - 2031 |
6.2.4 Global Celiac Drugs Market, Revenues & Volume, By Silent Celiac Disease, 2021 - 2031 |
6.3 Global Celiac Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Celiac Drugs Market, Revenues & Volume, By Topical, 2021 - 2031 |
6.3.3 Global Celiac Drugs Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.3.4 Global Celiac Drugs Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.5 Global Celiac Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Celiac Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Celiac Drugs Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Celiac Drugs Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.4.4 Global Celiac Drugs Market, Revenues & Volume, By Home Healthcare, 2021 - 2031 |
6.4.5 Global Celiac Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Celiac Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Celiac Drugs Market, Revenues & Volume, By Direct Tender, 2021 - 2031 |
6.5.3 Global Celiac Drugs Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.4 Global Celiac Drugs Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.5.5 Global Celiac Drugs Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.5.6 Global Celiac Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Celiac Drugs Market, Overview & Analysis |
7.1 North America Celiac Drugs Market Revenues & Volume, 2021 - 2031 |
7.2 North America Celiac Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Celiac Drugs Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Celiac Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Celiac Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Celiac Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7 North America Celiac Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Celiac Drugs Market, Overview & Analysis |
8.1 Latin America (LATAM) Celiac Drugs Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Celiac Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Celiac Drugs Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Celiac Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Celiac Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Celiac Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.7 Latin America (LATAM) Celiac Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Celiac Drugs Market, Overview & Analysis |
9.1 Asia Celiac Drugs Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Celiac Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Celiac Drugs Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Celiac Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Celiac Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.6 Asia Celiac Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.7 Asia Celiac Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Celiac Drugs Market, Overview & Analysis |
10.1 Africa Celiac Drugs Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Celiac Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Celiac Drugs Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Celiac Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Celiac Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.6 Africa Celiac Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.7 Africa Celiac Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Celiac Drugs Market, Overview & Analysis |
11.1 Europe Celiac Drugs Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Celiac Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Celiac Drugs Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Celiac Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Celiac Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.6 Europe Celiac Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.7 Europe Celiac Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Celiac Drugs Market, Overview & Analysis |
12.1 Middle East Celiac Drugs Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Celiac Drugs Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Celiac Drugs Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Celiac Drugs Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Celiac Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Celiac Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.6 Middle East Celiac Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.7 Middle East Celiac Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Celiac Drugs Market Key Performance Indicators |
14 Global Celiac Drugs Market - Export/Import By Countries Assessment |
15 Global Celiac Drugs Market - Opportunity Assessment |
15.1 Global Celiac Drugs Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Celiac Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Celiac Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Celiac Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.5 Global Celiac Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.6 Global Celiac Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Celiac Drugs Market - Competitive Landscape |
16.1 Global Celiac Drugs Market Revenue Share, By Companies, 2024 |
16.2 Global Celiac Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |